Life Science Investing Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
Life Science Investing Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
Life Science Investing Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology Annual Meeting
Life Science Investing Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference
Momentum Builds, Upside Appears as Mining Explorers Transition Toward Production, Unlock Major Hidden Value
Romios Proposes Name Change and Share Consolidation, Annual General and Special Meeting Scheduled for January 16, 2026
